DrugPrice

Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on "Drug Pricing in America: A Prescription for Change, Part II" February 26, 2019 in Washington, DC. From left to right are Richard A.…

Breadcrumb Trail Links PMN Business Medicare was cleared to negotiate drug prices for the first time by the Senate’s top rules official, though the Democrats’ proposal intended to cap price increases for prescription drugs in the…

By Victoria Knight and Colleen DeGuzman Sen. Joe Manchin and AARP “support government price-setting schemes” to divert money from Medicare to “unrelated government programs or pad big insurers’ profits.” Ad by American…